NCT03869476View on ClinicalTrials.gov

Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.

NACompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

July 30, 2019

Primary Completion Date

January 30, 2024

Study Completion Date

January 30, 2024

Conditions
Myeloproliferative DisorderEssential ThrombocythemiaPrimary Myelofibrosis, Prefibrotic StagePrimary Myelofibrosis, Fibrotic Stage
Interventions
DIAGNOSTIC_TEST

Non-invasive diagnosis score

"* spleen fibrosis by elastography~* plasma cytokines levels~* mutationnal landscape by NGS~* CD34 circulating cells"

Trial Locations (2)

29100

CHRU de Brest - Hôpital Morvan, Brest

49000

Chu Angers, Angers

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT03869476 - Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms. | Biotech Hunter | Biotech Hunter